Leadership & Pay ·
BioRestorative Therapies, Inc. dismissed CBIZ CPAs P.C. as its independent auditor effective August 28, 2026, and…
BRTXBioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. dismissed CBIZ CPAs P.C. as its independent auditor effective August 28, 2026, and engaged Bush & Associates CPA for the fiscal year ending December 31, 2026. The previous auditor's report on the 2025 financial statements included an explanatory paragraph expressing substantial doubt about the company’s ability to continue as a going concern. Katharyn Field resigned as Interim CEO, CFO, Treasurer, Secretary, and Board member effective August 26-31, 2026, entering into a consulting agreement for $10,000 monthly. The Board appointed Mika Grasso as Interim CEO and Anna Skowron as fractional CFO, both on consulting agreements with monthly fees of $10,000 and $12,000 respectively. Steven Brown was named Audit Committee Chair and Chairman of the Board. BioRestorative Therapies operates in the biotechnology industry, focusing on developing cell-based therapies.